Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer

Background: Oxaliplatin and capecitabine (CapeOX) combined with cetuximab is rarely used to treat advanced and metastatic colorectal cancer (mCRC). The present study aimed to clarify the clinical benefits of this treatment regimen when used as a first-line therapy in patients with expanded RAS/BRAF/...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cancer
Hoofdauteurs: Iwamoto, Shigeyoshi, Maeda, Hiromichi, Hazama, Shoichi, Oba, Koji, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Suzuki, Nobuaki, Nagano, Hiroaki, Sakamoto, Junichi, Mishima, Hideyuki, Nagata, Naoki
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2018
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277612/
https://ncbi.nlm.nih.gov/pubmed/30519308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.26840
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items